MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Medical Devices & Technology (Technology)
*Driving Forces: Telemedicine,Telehealth, Mobile Health, mHealth, Virtual, Digital Health, DTx (Digital Therapeutics)
*Driving Forces: Telemedicine,Telehealth, mHealth & Home Health (Sectors)
*Driving Forces: Primary Care, Chronic Disease, Wellness, Weight Loss, Obesity, Coordinated Care
*Pioneers: Cardiology & Cardiovascular
Medical & Clinical Specialities
Diseases, Illnesses, Injury & Injuries
Cancer, Oncology
MCED (Multi-Cancer Early Detection)
Parents
Cancer
Cancer, Oncology
Children
*Driving Forces: Cancer and Oncology
*Funding: Diagnostics_Liquid Biopsy
2025: Routine Liquid Biopsies Could Substantially Reduce Late-Stage Cancer Diagnoses
2025:Only 4 cancers are routinely screened. From promise to practice: MCED adoption accelerates despite operational hurdle
Liquid Biopsy
Through this Notice of Request for Information (RFI), the National Cancer Institute (NCI) is soliciting input from developers about Multi-Cancer Early Detection (MCED) liquid biopsy tests and about their interest in participating in an NCI-sponsored clinical utility platform randomized controlled screening trial.